Search
Etuvetidigene Autotemcel
go.drugbank.com/drugs/DB17593ApprovedInvestigationalEtuvetidigene autotemcel is an autologous gene therapy which includes hematopoietic stem cells (HSCs) that have been genetically modified ex vivo. First approved by the FDA on December 9, 2025, etuvetidigene autotemcel is used to treat W...
Dihexyverine
go.drugbank.com/drugs/DB13678ExperimentalCategories: Drugs for Functional Gastrointestinal DisordersTriflusal
go.drugbank.com/drugs/DB08814ApprovedWithdrawnUriach and Company and even though it is commercialized in different countries it is not approved by the FDA, EMA or HealthCanada.
Cilansetron
go.drugbank.com/drugs/DB04885ExperimentalCilansetron is a 5HT-3 antagonist made by Solvay Pharmaceuticals that is currently under trial phase in the EU and US.
Categories: Drugs for Functional Gastrointestinal DisordersFelbinac
go.drugbank.com/drugs/DB07477InvestigationalCategories: Topical Products for Joint and Muscular Pain, Antiinflammatory Preparations, Non-Steroids for Topical UseRufloxacin
go.drugbank.com/drugs/DB13772InvestigationalRufloxacin is a quinolone antibiotic.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseD-Cysteine
go.drugbank.com/drugs/DB03201ExperimentalA thiol-containing non-essential amino acid that is oxidized to form CYSTINE.
VA-MENGOC-BC®
go.drugbank.com/drugs/DB15800ExperimentalAs of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials. … As there already exists a polysaccharide-based vaccine against meningococcal disease originating from serogroups A,C,W135, and Y, this vaccine was created for use against serogroups B and C.
Suxibuzone
go.drugbank.com/drugs/DB13232ExperimentalCategories: Topical Products for Joint and Muscular Pain, Antiinflammatory Preparations, Non-Steroids for Topical Use